Farallon Capital Management’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-330,619
| Closed | -$357K | – | 180 |
|
|
2023
Q2 | $357K | Sell |
330,619
-368,423
| -53% | -$398K | ﹤0.01% | 132 |
|
|
2023
Q1 | $509K | Sell |
699,042
-114,514
| -14% | -$83.4K | ﹤0.01% | 148 |
|
|
2022
Q4 | $911K | Sell |
813,556
-186,444
| -19% | -$209K | 0.01% | 174 |
|
|
2022
Q3 | $1.76M | Hold |
1,000,000
| – | – | 0.01% | 206 |
|
|
2022
Q2 | $1.56M | Sell |
1,000,000
-147,400
| -13% | -$230K | 0.01% | 209 |
|
|
2022
Q1 | $2.27M | Sell |
1,147,400
-202,600
| -15% | -$401K | 0.01% | 211 |
|
|
2021
Q4 | $6.28M | Buy |
+1,350,000
| New | +$6.28M | 0.03% | 169 |
|